Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
An overview of which total market fund performed best in 2024, with notes on expense, tracking error, and performance drivers.
28,518 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
New SPIVA data shows 9 in 10 active large-cap funds underperform the S&P 500 over 15 years, a reality that challenges...
Kingsoft Cloud KC 2026 Q1 sets the tone for the year. This guide breaks down what to watch in margins, segments, and ...
When rocket stock plummeted today, investors watched a high-growth space company slide on sentiment and macro cues. T...
The SEC has proposed scrapping Rule 611 and Rule 610(e), a step that could transform tokenized US stocks trading in D...
SpaceX’s sharp stock surge lifts market mood as oil prices slip, pushing the Nasdaq toward fresh highs. Analysts say ...
Summit Sotheby’s International Realty dominates Utah’s 2026 RealTrends Verified rankings, placing the most agents in ...
Next week could push the stock market in new directions. Here are three essential signals plus practical moves to sta...
Anthropic’s confidential $965 filing signals big ambitions in AI equity. This guide breaks down what it means, how pr...
As Iran escalates into conflict 2.0 and mortgage rates linger near the sixes, the housing market faces new tests. Thi...
The Digital Chamber launches the Prediction Markets Working Group to win federal oversight for prediction markets, se...
The housing muni market swells as affordability policy debates unfold, fueling a surge in bond issuance to fund low-c...